1358
J. Clayden et al. / Tetrahedron: Asymmetry 21 (2010) 1355–1360
for the reliable use of the ligands in asymmetric transformations.
We are currently developing analogues with greater stability to
racemisation obtainable by replacement of the methyl groups with
substituents of greater steric bulk and seeking to apply these li-
gands as chiral analogues of DPEPhos or xantphos in new asym-
metric reactions.
using OT+ column running 98:2 hexane/IPA at 0.6 ml/min, retention
times 9.9 and 11.2 min.
4.2.3. (2-(2-tert-Butylphenylsulfonyl)-3-tert-butylphenyl)
diphenylphosphane 6c
A solution of sec-BuLi (1.3 M in hexanes, 1.05 mL) was added
dropwise to a solution of sulfone 23 (150 mg) in anhydrous THF
(10 mL) in a flame-dried flask under an atmosphere of nitrogen
at ꢀ78 °C and stirred for 30 min. Chlorodiphenyl phosphine
(0.29 mL) was added dropwise and the reaction was stirred and al-
lowed to warm to rt over 16 h. The reaction was quenched by addi-
tion of solid silica gel (ꢃ300 mg) and the solvents were removed
under reduced pressure. Dry silica was loaded onto a pre packed
flash chromatography column and the crude product was purified
eluting with petrol increasing to 6:1 petrol/ethyl acetate to yield
the title compound as a white solid (196 mg, 84%); Rf = 0.65 (4:1
petrol/ethyl acetate); dC (75 MHz, CDCl3) 152.7, 152.7, 149.1,
148.8, 145.3, 143.5, 137.4, 133.4, 133.1, 133.0, 131.6, 131.4,
130.1, 129.7, 129.1, 129.1, 128.2, 128.1, 124.8, 38.7, 37.6, 33.1,
32.1; ES m/z 515 (100%, [M+H]+), 537 (50% [M+Na]+).
4. Experimental
4.1. General procedure for halogen?Li?PPh2 exchange
nBuLi (1 equiv) was added dropwise to a stirring solution of
halo arene (1 equiv) in anhydrous THF at ꢀ78 °C under N2 and stir-
red for 1 min, unless otherwise stated. The electrophile was added
and the mixture was stirred for 16 h with warming to rt. The reac-
tion was quenched by addition of saturated ammonium chloride
solution and the mixture was diluted using EtOAc. The layers were
separated and the organic fraction was washed with water, brine,
dried (Na2SO4), and the solvent was removed under reduced
pressure.
4.2.4. 1-Diphenylphosphanyl-2-(20-diphenylphospha-
4.2. Starting materials
nylphenoxy)-3-(methoxymethyl)benzene 7a
Dibromide 15 (250 mg, 0.67 mmol, 1 equiv), nBuLi (1.4 M solu-
tion in hexanes) (0.96 cm3, 1.34 mmol, 2 equiv), chlorodiphenyl-
phosphine (0.36 cm3, 2.02 mmol, 3 equiv) and THF (12 cm3) were
treated as described in Section 4.1 and stirred for 90 s before
quench. The crude product was purified several times by flash col-
umn chromatography (40:1 petrol/EtOAc), finally yielding the
product as a white solid (11 mg, 3%), mp 162–166 °C. Rf = 0.61
Aryl bromides 13–15 were made by the method of Clayden
et al.4a,b Aryl iodides 20 and 21 were made by the method of Betson
et al.7 Sulfones 22 and 23 were made by the method of Clayden
et al.4c,8a
4.2.1. [2-(20-Isopropylphenoxy)-3-(methoxymethyl)
phenyl]diphenylphosphane 6a
(19:1 petrol/EtOAc); mmax (film/cmꢀ1
) 1433, 1422 (PPh2); dH
Bromide 13 (44 mg, 0.13 mmol, 1 equiv), nBuLi (1.7 M solution
in hexanes) (0.08 cm3, 0.13 mmol, 1 equiv), chlorodiphenylphos-
phine (0.03 cm3, 0.14 mmol, 1.1 equiv) and THF (4 cm3) were trea-
ted as described in Section 4.1. The crude product was purified by
flash column chromatography (35:1 petrol/EtOAc) to yield the
product as a colourless oil (18 mg, 31%). Rf = 0.58 (19:1 petrol/
EtOAc); mmax (film/cmꢀ1) 1449, 1434, 1424 (PPh); dH (300 MHz;
CDCl3) 7.59 (1H, d, J 7.5, H-3), 7.41–7.20 (13H, m, ArH, H-1, H-2
and H-4), 6.94 (1H, m, H-5), 6.87 (1H, m, H-6), 6.32 (1H, m, H-7),
4.43–4.18 (2H, CH AB m, J 13, H-8), 3.32 (3H, s, H-9), 3.16 (1H, sept,
J 7, H-10) and 0.90 (6H, d, J 7, H-11).; dC (75 MHz; CDCl3) 155.2,
154.3, 154.1, 136.3, 135.0, 134.7, 134.4, 133.8, 133.4, 132.2,
130.1, 129.1, 128.7, 128.6, 128.5, 126.6, 126.5, 125.8, 121.9,
112.9, 110.0, 69.2, 58.7, 26.8 and 22.9.; CI m/z 441 (M+H); (found:
M+H, 441.1957. C29H30O2P requires M, 441.1978). VT NMR; In
DMSO-d6 run from rt to 150 °C, modelling H-8 coalescence ob-
served between 90 and 100 °C.
(300 MHz; CDCl3) 7.50 (1H, ddd, J 7.5, 1 and 0.5, ArH), 7.34–7.21
(H, m, ArH), 7.17 (1H, t, J 8, ArH), 7.13 (1H, td, J 8 and 2, ArH),
7.03 (1H, ddd, J 8, 1 and 0.5, ArH), 6.86 (2H, m, ArH), 6.77 (1H,
dd, J 7.5 and 2, ArH), 6.75 (1H, dd, J 7.5 and 2, ArH), 6.30 (1H, dd,
8 and 4.5, ArH), 4.05 (2H, s, CH2OCH3) and 3.16 (3H, s, OCH3).; dC
(75 MHz; CDCl3) 159.9, 159.7, 137.3, 136.7, 136.6, 134.8, 134.6,
134.5, 134.4, 134.3, 134.0, 133.7, 133.4, 132.6, 132.4, 130.0,
129.6, 129.0, 128.9, 128.6, 128.5, 128.5, 128.4, 128.4, 128.4,
128.3, 126.0, 125.5, 122.1, 113.1, 68.8 and 58.6.; CI m/z 583
(M+H); (found: M+H, 583.1951. C38H33O2P2 requires M, 583.1950).
4.2.5. (2-(4-Methyl-2-(diphenylphosphino)phenoxy)-3,5-dimeth
ylphenyl)diphenylphosphane 7b
Diiodide 20 (679 mg, 1.62 mmol, 1 equiv), nBuLi (2.3 M solution
in hexanes) (1.4 cm3, 3.23 mmol, 2 equiv), chlorodiphenylphos-
phine (0.7 cm3, 3.88 mmol, 2.4 equiv) and THF (30 cm3) were trea-
ted as described in Section 4.1 H and stirred for 90 s before
quench. The crude product was purified by flash column chromatog-
raphy (150:1 petrol/EtOAc) to yield the product as a white foam
(342 mg, 68%), mp 74–78 °C. Rf = 0.79 (50:1 petrol/EtOAc); mmax
(film/cmꢀ1) 1434 (PPh).; dH (500 MHz; CDCl3) 7.22–7.09 (18H, m,
ArH), 6.99 (2H, td, J 7.5 and 1.5, ArH), 6.89 (1H, br s, ArH), 6.77 (1H,
dd, J 8 and 2, ArH), 6.45 (1H, dd, J 4.5 and 2, ArH), 6.41 (1H, br t, J 3,
ArH), 6.17 (1H, dd, J 8 and 4.5, ArH), 2.08 (3H, s, ArCH3), 2.03 (3H, s,
ArCH3) and 1.77 (3H, s, ArCH3).; dC (75 MHz; CDCl3) 157.9, 157.7,
153.7, 153.4, 137.8, 137.4, 137.1, 136.9, 136.9, 136.8, 134.9, 134.8,
134.6, 134.6, 134.5, 134.4, 134.2, 134.0, 133.6, 133.5, 133.4, 132.3,
132.0, 131.8, 131.4, 131.3, 130.8, 130.7, 128.7, 128.6, 128.5, 128.5,
128.4, 128.4, 126.3, 128.2, 128.2, 124.9, 124.7, 112.8, 21.2, 20.9
and 16.7.; APCI– m/z 580 (M); APCI+ m/z 581 (M+H).
4.2.2. [2-(20-tert-Butylphenoxy)-3-(methoxymethyl)
phenyl]diphenylphosphane 6b
Bromide 14 (103 mg, 0.31 mmol, 1 equiv), nBuLi (1.7 M solution
in hexanes) (0.18 cm3, 0.31 mmol, 1 equiv), chlorodiphenylphos-
phine(0.06 cm3, 0.34 mmol, 1.1 equiv)andTHF(8 cm3)weretreated
as described in Section 4.1. The crude product was purified by flash
column chromatography (50:1 petrol/EtOAc) to yield the product
as a white solid (48 mg, 34%), mp 100–103 °C. Rf = 0.55 (19:1 pet-
rol/EtOAc); m
max (film/cmꢀ1) 1422 (PPh); dH (300 MHz; CDCl3) 7.63
(1H, ddd, J 7.5, 1.5 and 0.5, H-3), 7.39–7.22 (12H, m, ArH, H-2 and
H-4), 6.97–6.89 (3H, m, H-1, H-5 and H-6), 6.32 (1H, m, H-7), 4.46–
4.13 (2H, CH AB m, J 12.5, H-8), 3.30 (3H, s, H-9) and 1.37 (9H, s, H-
10).; dC (75 MHz; CDCl3) 157.2, 154.4, 154.2, 136.9, 136.9, 136.7,
134.8, 134.6, 134.2, 133.7, 133.5, 132.5, 132.3, 132.0, 132.0, 130.4,
129.0, 128.6, 128.6, 128.5, 128.5, 127.3, 127.0, 125.9, 121.6, 113.9,
69.4, 58.7, 35.0 and 30.0.; EI m/z 455 (M); CI m/z 455 (M); (found:
M, 455.2143. C30H32O2P requires M, 455.2134). HPLC; separation
4.2.6. Bis(2,4-dimethyl-6-(diphenylphosphanyl)phenyl ether 7c
Diiodide 21 (254 g, 0.53 mmol, 1 equiv), nBuLi (2.3 M solution in
hexanes) (0.46 cm3, 1.06 mmol, 2 equiv), chlorodiphenylphosphine
(0.21 cm3, 1.17 mmol, 2.2 equiv) and THF (15 cm3) were treated as